News and Insights of 3D Printing and Manufacturing
UPM, a Finnish alternative energy and material company, has launched a range of bioinks known as GrowInk, designed for various 3D bioprinting applications such as tissue engineering and regenerative medicine.
Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) in North Carolina have 3D bioprinted a microscopic model of the human body containing most of the vital organs. The miniature system will be used to detect potentially harmful effects of drugs before they are trialed with humans.
Merck, the global pharmaceutical company, has announced plans to work with AMCM, an EOS Group company that builds custom additive manufacturing machines. The two companies will work on developing and producing 3D printed tablets, first for clinical trials, then later for commercial manufacturing.
UK-based engineering technologies company, Renishaw, has announced a milestone in a medical study seeking to help sufferers with progressive nervous system disorder Parkinson disease. The study looks at a patented intraparenchymal drug delivery device and is the completion of a joint Phase 1-2 clinical study with pharmaceuticals expert Herantis Pharma.
Biomedical engineers from Rutgers University in New Jersey have developed a bio-ink for 3D printing that enables the construction of scaffolds to support growing human tissues. Significantly, the stiffness of the scaffolds can be controlled depending on the mixture of ink used, enabling applications for different types of tissues for repair or replacement.
With Italy now at the center of active Coronavirus cases, the country is in lockdown to combat the rapid spread of COVID-19. The large number of cases means that, inevitably, a huge strain has been placed on Italy’s healthcare system, and its supply chain.
A research team from the US Department of Energy’s Argonne National Laboratory has successfully scaled up the recycling of an important medical isotope using 3D printed parts. The new additively manufactured parts make the laboratory’s original recycling process – invented in 2015 – faster, more reliable and less costly, enabling the method to potentially be used on an industrial scale.
3D printed implant developer Osteopore has partnered with the National University of Singapore (NUS) spin-off Magloy Tech to commercialize its new OrthoMag bone graft product.
Chinese 3D printing technology startup Triastek has raised $15 million in Series A funding to accelerate the research and development of its 3D printed drugs.
Shanghai-based 3D printer manufacturer INTAMSYS has helped Swedish pharmaceutical firm ABIGO Medical keep its production line running by filling a delivery gap of spare parts with re-engineered 3D printed substitutes.